ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

ASCO proposes compromise to limit payment cuts proposed by Congress, CMS.

September 12, 2003

Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups

July 8, 2011

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

Komen Foundation Calls For Review Of Action Plan’s Goals

October 24, 1996

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984